Eclipsys posts strong Q3 results

Eclipsys reported strong financial results for its fiscal 2007 third quarter (end-Sept. 30), showing an upturn in revenues and income.

The Atlanta-based company posted revenues of $121.1 million in the third quarter 2007, an 11.5 percent increase compared to $108.6 million for the same quarter last year.

Based on generally accepted accounting principles, the firm reported a net income for the third-quarter of 2007 of $8.9 million, a 58.9 percent increase compared to $5.6 million for the year-ago quarter.

The company said it estimates 2007 annual revenues will be slightly down from earlier guidance, from $473 million to $476 million, mainly due to the company's decision to exit the networking services business.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.